"We see more opportunities within equities for investors searching for yield," Bank of America's Sa…

JPMorgan said it expects Structure Therapeutics' oral GLP-1 weight loss drug candidate to generate …

US stock futures slid on Wednesday as Amazon's evidence of strong AI demand was tempered by signs o…

Nividia is still a retail darling, but last week saw individual investors pivot to names like Eli L…

India’s benchmark indices Sensex and Nifty50 were flat in morning trade on Tuesday amidst positive …

A September rate cut would come shortly before another major economic event: the US presidential el…

Arena's stock surge comes after the price this year had dropped by 35%.

The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…

The agreement is an early sign that, despite the threat of close antitrust examinations and higher …

Pfizer cleared a massive resistance level last week when it surged above its record high of $47.39 …

Pfizer had originally invested $25 million in Trillium in September of last year, as part of its br…

Shares of Pfizer jumped to a high of $48.57 on Tuesday, more than a dollar higher than its previous…

Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.

In today's big story, we're looking at pharma companies' surging stocks and threatening tech darlin…

The EU's drug regulator is looking at reports about skin rash and kidney problems.

The CDC's guidance to pause the use of J&J's COVID vaccine came following reports of 6 rare blood c…

Vaccine demand is likely to persist well into next year, the company said, with more than a billion…

Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…

Regulators are now working "rapidly" to finalize authorization of Pfizer's shot, FDA Commissioner S…

The companies aim to apply for emergency-use authorization within days. If approved, the vaccine co…